Tag results:
mesenchymal stem cells
Mesenchymal Cell News
Human Umbilical Cord Mesenchymal Stem Cells in Type 2 Diabetes Mellitus: The Emerging Therapeutic Approach
[Cell and Tissue Research] The authors focus on the latest research and applications of human-derived umbilical cord MSC in the treatment and management of T2DM, exploring and systematizing the key effects of both umbilical cord MSC and its factor-rich secretome accordingly with the major complications associated to T2DM.
Extracellular Matrix News
Inhibition of Aberrant Tissue Remodeling by Mesenchymal Stromal Cells Singly Coated with Soft Gels Presenting Defined Chemomechanical Cues
[Nature Biomedical Engineering] The authors showed that MSCs singly coated with a soft conformal gel presenting defined chemomechanical cues promoted matrix remodeling by secreting soluble interstitial collagenases in response to the presence of tumour necrosis factor alpha.
Mesenchymal Cell News
The N6-Methyladenosine Demethylase ALKBH5 Negatively Regulates the Osteogenic Differentiation of Mesenchymal Stem Cells through PRMT6
[Cell Death & Disease] Researchers showed that conditional knockout of the demethylase Alkbh5 in bone marrow MSCs strengthened bone mass in mice.
Umbilical & Placental Cell News
3D Bioprinting of Polythiophene Materials for Promoting Stem Cell Proliferation in a Nutritionally Deficient Environment
[ACS Applied Materials & Interfaces] PMNT was confirmed to promote human umbilical cord-derived MSC proliferation in a serum-free medium by driving cell cycles and up-regulating gene expression in the pathways of biosynthesis and the metabolism.
Umbilical & Placental Cell News
Matrigel/Umbilical Cord-Derived Mesenchymal Stem Cells Promote Granulosa Cell Proliferation and Ovarian Vascularization in a Mouse Model of Premature Ovarian Failure
[Stem Cells and Development] Investigators aimed to fabricate a Matrigel scaffold loaded with human umbilical cord-derived MSCs and explore its potential to restore ovarian function and repair ovarian structures in vitro and in vivo.
Human Immunology News
Human-Derived Treg and MSC Combination Therapy May Augment Immunosuppressive Potency In Vitro, but Did Not Improve Blood Brain Barrier Integrity in an Experimental Rat...
[PLOS One] Researchers compared the ability of regulatory T cells (Treg) + mesenchymal stromal cells (MSC) combination therapy, as well as MSC and Treg monotherapies, to improve blood brain barrier permeability in vivo and suppress inflammation in vitro.